Home › Funds › CPP Investments › ARVN
CPP Investments position in ARVN
ARVINAS INC · Health Care
Latest position (Q2 2026)13.50K sh
Reported value held$112.19K
Portfolio Weight0.00%
First reportedQ4 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 17.30K | $331.64K | New |
| Q1 2025 | 3.20K | $22.46K | Reduce |
| Q1 2025 | 3.20K | $22.46K | Reduce |
| Q2 2025 | 6.70K | $49.31K | Add |
| Q2 2025 | 6.70K | $49.31K | Add |
| Q3 2025 | 6.00K | $51.12K | Reduce |
| Q4 2025 | 30.50K | $361.73K | Add |
| Q1 2026 | 14.50K | $153.70K | Reduce |
| Q2 2026 | 13.50K | $112.19K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ARVN
- Vanguard Group 7.23M sh · $85.74M · Q4 2025
- BlackRock Inc 7.61M sh · $63.23M · Q2 2026
- D. E. Shaw & Co 3.50M sh · $29.04M · Q2 2026
- Two Sigma Investments 2.57M sh · $21.39M · Q2 2026
- Geode Capital Management 1.67M sh · $13.86M · Q2 2026
- Goldman Sachs Group 640.81K sh · $5.33M · Q2 2026
- Northern Trust Corp 615.30K sh · $5.11M · Q2 2026
- AQR Capital Management 601.87K sh · $5.00M · Q2 2026
- Millennium Management 574.01K sh · $4.77M · Q2 2026
- Charles Schwab Investment Management 542.17K sh · $4.51M · Q2 2026
- Morgan Stanley 502.75K sh · $4.18M · Q2 2026
- UBS Group AG 444.67K sh · $3.70M · Q2 2026